<DOC>
	<DOCNO>NCT00181649</DOCNO>
	<brief_summary>The purpose study ass safety determine effect hormone prolactin lactation ( breast milk production ) .</brief_summary>
	<brief_title>Recombinant Human Prolactin Lactation Induction</brief_title>
	<detailed_description>Subjects participate randomize , double-blind , placebo-controlled , crossover trial compare breast pumping , alone , breast pump r-hPRL . Subjects one week instruction breast pump alone . Subsequently , subject receive 2 week r-hPRL placebo follow 2 week alternate treatment . Week 1 : Study day 1 , baseline prolactin level obtain subject teach use electrical , hospital grade breast pump designate lactation consultant . Subjects pump 10 minute breast . The total volume milk record diary throughout study . Prolactin level obtain every 10 minute 60 minute pump begin , every 30 minute total 3 hour . Subjects pump 3 time per day increase 8 time per day end first week continue regimen throughout study . Week 2 : One week initial visit , subject return GCRC re-evaluation pumping technique first dose medication . Subjects pump 10 minute breast day 1 prolactin level obtain every 10 minute 60 minute , every 30 minute total 3 hour . At 3 hour , r-hPRL 60 mg/kg placebo administer SC . Blood drawn every 10 minute 60 minute , every 30 minute 2 hour , 4 , 6 8 hour obtain peak prolactin level . Vital sign monitor every 15 minute first hour , every 2 hour total 8 hour . Subjects pump breast every 3 hour , start r-hPRL placebo injection . Subjects teach give SC injection administer second dose SC r-hPRL placebo 12 hour first dose . Subjects continue SC r-hPRL placebo administration every 12 hour next 14 day . They continue pump daily , approximately every 3 hour , 5 hour break night sleep . Subjects ask refrigerate milk bring GCRC visit prolactin level . Subjects return weekly 4 additional visit ( week 3 , 4 , 5 , 6 ) . At weekly visit , blood drawn baseline prolactin level r-hPRL placebo administer . Blood drawn every 10 minute 60 minute , every 30 minute 2 hour , every 2 hour total 8 hour injection . Vital sign monitor describe . At week 4 visit , subject switch alternate treatment week 4 5 . Subjects see 14 day final injection . A baseline prolactin level drawn , milk pump , previously . Blood drawn every 10 minute 60 minute , every 30 minute total 3 hour . A 1 cc sample milk also obtain 14 day final injection analysis composition . All side effect r-hPRL record throughout study . All milk obtain study store milk composition determine use . Infants receive milk produce study initially monitor GCRC supervision neonatologist .</detailed_description>
	<criteria>Healthy , nonpostpartum woman , age 1845 year , desire lactate adoptive child Normal thyroidstimulating hormone ( TSH ) prolactin level Normal adrenal gland function take physiological glucocorticoid replacement No medical illness contraindicate breastfeed HIV negative Normal breast development Use medication know increase prolactin Anatomical breast abnormality Previous mammoplasty breast augmentation Current use hormonal contraception Allergies mannitol Medications contraindicate breastfeed mother</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Lactation</keyword>
	<keyword>Breastfeeding</keyword>
	<keyword>Adoptive mother</keyword>
	<keyword>Prolactin</keyword>
	<keyword>Relative lactation insufficiency</keyword>
</DOC>